ArticlemBio2022

The FDA-Approved Drug Cobicistat Synergizes with Remdesivir To Inhibit SARS-CoV-2 Replication

Iart Luca Shytaj et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.